用户反馈
提交
谢谢您的反馈，如果有主动联系我们的需要，
请发送邮件至：marketing@echemi.com，电话联系：400-660-1110
Subject: Survey – Access and commercialization of molecules for obesity research and development. Dear Sir or Madam, As part of a research and development project on obesity, I would like to obtain information regarding access and commercialization. We also wish to develop the following markets with generics: North Africa and certain African countries. We are conducting research on the following molecules: Semaglutide (C151H226N40O46) 1 mg – 5 mg Tirzepatide (C225H348N48O68) 5 mg – 10 mg Cagrilintide (C230H414N72O68S2) Could you please inform me of the following points: In what forms do you offer these molecules? Do you offer them as injector pens or other devices? If so, do they come with a box and needles? What is the minimum order quantity? Do you also offer peptide powders? Thank you in advance for your response. I remain at your disposal for any additional information. Sincerely, Coralie LEBON, For slimeurope Sent via Proton M secure messaging